Bionano Genomics Acquires Purigen Biosystems for up to $64 Million
Bionano Genomics has acquired Purigen Biosystems in a deal valued at up to $64 million. This includes $32 million in cash paid at closing subject to adjustment for, among other things, cash, unpaid indebtedness, unpaid transaction expenses and net working capital relative to a specified target. The remainder of the consideration is contingent on the achievement of certain milestones. The deal is expected to close on or before December 8, 2022. Pleasanton, California-based Purigen Biosystems focuses on redefining nucleic acid sample preparation with a platform based on the isotachophoresis technology. Bionano Genomics, which is located in San Diego, provides genome analysis solutions that... Read More »
Cambrex Acquires Snapdragon Chemistry
East Rutherford, New Jersey-based Cambrex Corporation has acquired Snapdragon Chemistry of Waltham, Massachusetts. Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing automation technology and proprietary equipment to solve complex process and analytical development challenges. Cambrex is a global contract development and manufacturing organization (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle. The transaction is expected to close following the completion of customary regulatory approvals. This will be Cambrex’s second acquisition within a year along with... Read More »
Telix Pharmaceuticals Acquires Optimal Tracers
Telix Pharmaceuticals Limited has acquired Sacramento, California-based Optimal Tracers. Optimal Tracers is a division of Northern California PET Imaging Center, a not-for-profit business providing clinical and clinical trial imaging services in northern California. Optimal Tracers provides manufacturing and development radiochemistry services in support of academic and pharmaceutical research activities. Telix Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical needs in oncology and... Read More »
Avalon GloboCare Purchases Laboratory Services
Avalon GloboCare Corp. (NASDAQ: AVCO) announced its acquisition of Laboratory Services MSO, LLC on November 8. The purchase price, for 60% of the company, totaled $31 million. Shares of Avalon’s common stock began trading under the new ticker symbol “ALBT” on the Nasdaq Capital Market on Thursday, November 10, 2022. Revere Securities LLC is acting as an advisor to Avalon in the transaction. Lowenstein Sandler LLP is acting as legal counsel to Avalon in the transaction. Blythe Global LLC is acting as accounting advisor. Headquartered in Costa Mesa, California, Laboratory Services MSO provides a broad portfolio of diagnostic tests including drug testing, toxicology and a wide array of test... Read More »
Werfen Acquires Immucor From TPG for $2 Billion
Barcelona-based Werfen announced on November 3 its acquisition of Immucor, Inc., a Norcross, Georgia-based provider of transfusion and transplantation diagnostic products worldwide, from San Francisco-based private equity firm TPG Capital. This acquisition will allow Werfen to expand its portfolio of specialized diagnostics solutions for hospitals and clinical laboratories. According to the LevinPro HC database, this marks the 114th acquisition in the Laboratories, MRI and Dialysis sector this year, and the 63rd deal in the diagnosis subsector. The purchase price is expected to be approximately $2 billion, with closing subject to customary regulatory approvals. The acquisition is being... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
